Venkatesh, D.* ; O'Brien, N.A.* ; Zandkarimi, F.* ; Tong, D.R.* ; Stokes, M.E.* ; Dunn, D.E.* ; Kengmana, E.S.* ; Aron, A.T.* ; Klein, A.M.* ; Csuka, J.M.* ; Moon, S.H.* ; Conrad, M. ; Chang, C.J.* ; Lo, D.C.* ; D'Alessandro, A.* ; Prives, C.* ; Stockwell, B.R.*
MDM2 and MDMX promote ferroptosis by PPARα-mediated lipid remodeling.
Genes Dev. 34, 526-543 (2020)
MDM2 and MDMX, negative regulators of the tumor suppressor p53, can work separately and as a heteromeric complex to restrain p53's functions. MDM2 also has pro-oncogenic roles in cells, tissues, and animals that are independent of p53. There is less information available about p53-independent roles of MDMX or the MDM2-MDMX complex. We found that MDM2 and MDMX facilitate ferroptosis in cells with or without p53. Using small molecules, RNA interference reagents, and mutant forms of MDMX, we found that MDM2 and MDMX, likely working in part as a complex, normally facilitate ferroptotic death. We observed that MDM2 and MDMX alter the lipid profile of cells to favor ferroptosis. Inhibition of MDM2 or MDMX leads to increased levels of FSP1 protein and a consequent increase in the levels of coenzyme Q(10), an endogenous lipophilic antioxidant. This suggests that MDM2 and MDMX normally prevent cells from mounting an adequate defense against lipid peroxidation and thereby promote ferroptosis. Moreover, we found that PPAR alpha activity is essential for MDM2 and MDMX to promote ferroptosis, suggesting that the MDM2-MDMX complex regulates lipids through altering PPAR alpha activity. These findings reveal the complexity of cellular responses to MDM2 and MDMX and suggest that MDM2-MDMX inhibition might be useful for preventing degenerative diseases involving ferroptosis. Furthermore, they suggest that MDM2/MDMX amplification may predict sensitivity of some cancers to ferroptosis inducers.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Ferroptosis ; Mdm2 ; Mdmx ; P53-independent ; Ppar Alpha ; Lipid Metabolism ; Fsp1 ; Coq(10) ; Cancer; Proliferator-activated Receptor; Cell-death; P53; Metabolism; Inhibitors; Identification; Oxidation; Apoptosis; Complex; Target
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2020
Prepublished im Jahr
HGF-Berichtsjahr
2020
ISSN (print) / ISBN
0890-9369
e-ISSN
1549-5477
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 34,
Heft: 7-8,
Seiten: 526-543
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
Cold Spring Harbor Laboratory Press
Verlagsort
1 Bungtown Rd, Cold Spring Harbor, Ny 11724 Usa
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-506900-001
Förderungen
Copyright
Erfassungsdatum
2020-04-20